Read the latest press releases for 4D pharma plc.

Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.

Presentations
4D pharma to Present at Upcoming Investor Conferences in March
3 Mar 2021, 07:00
4D pharma management will present and meet with investors at three upcoming investor conferences…
Careers
4D pharma Appoints Paul Maier to the Board as Non-Executive Director
1 Mar 2021, 07:00
4D pharma announces the appointment of Paul Maier as Non-Executive Director of the Board. Mr Maier…
Careers
4D pharma Appoints John Beck as Chief Financial Officer
1 Mar 2021, 07:00
4D pharma announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the…
4D pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ
26 Feb 2021, 07:00
4D pharma to list ADSs on NASDAQ in conjunction with the merger agreement between 4D pharma and…
4D pharma to Participate in Cantor Fitzgerald Microbiome Leaders Panel
16 Feb 2021, 07:00
Duncan Peyton, Chief Executive Officer of 4D pharma, will participate in Cantor Fitzgerald's virtual…
4D pharma presents update on oncology program
3 Feb 2021, 07:00
4D pharma announces progress on activities in its development program for lead immuno-oncology…
4D pharma to Participate in 5th Microbiome Movement Drug Development Summit Europe
21 Jan 2021, 08:00
4D today announces its participation in the Microbiome Movement Drug Development Summit - Europe,…
4D pharma Joins Landmark Parkinson’s Progression Markers Initiative
18 Dec 2020, 08:25
A landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson’s disease…
4D pharma plc Files SEC Forms in Process to Gain NASDAQ Listing Following Merger with Longevity, a Special Purpose Acquisition Company (SPAC)
26 Nov 2020, 07:00
Merger completion and NASDAQ listing expected in Q1 2021. US listing will support and accelerate…
4D pharma presents new data from two MRx0518 clinical trials at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
9 Nov 2020, 13:00
MRx0518 demonstrates upregulation of key immune biomarkers associated with anti-cancer activity in…
4D to Host Virtual KOL Event Reviewing MRx0518 Data To Be Presented at SITC 2020
5 Nov 2020, 12:00
4D Pharma to Host Virtual KOL Event Reviewing New Data Presented at the SITC Annual Meeting 2020…
4D pharma plc announces merger with Longevity, a special purpose acquisition company (SPAC), and its intention to gain a NASDAQ listing
22 Oct 2020, 07:00
4D pharma plc announces merger with Longevity, a special purpose acquisition company (SPAC), and its…
4D pharma announces topline results from Blautix® Phase II trial in irritable bowel syndrome (IBS)
7 Oct 2020, 07:00
4D pharma announces topline results from Blautix® Phase II BHT-II-002 trial in IBS-C and IBS-D

BACK TO TOP